SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 29th, 2019 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 20, 2018, by and between TAURIGA SCIENCES, INC., a Florida corporation, with headquarters located at 555 Madison Avenue, 5th Floor, New York, NY 10022, (the “Company”), and Adar Alef, LLC, a New York limited liability company, with its address at 38 Olympia Ln, Monsey, NY 10952 (the “Buyer”).
SECURITIES PURCHASE AGREEMENT Tauriga Sciences Inc. (OTCQB: TAUG) New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer. DATE: January 8, 2019Securities Purchase Agreement • January 29th, 2019 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 8, 2019, by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”), and the Subscriber identified on the signature pages hereto (the “Subscriber”).
New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer AGREEMENT FOR CONSULTANT TO THE COMPANY WithConsultant Agreement • January 29th, 2019 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • Florida
This (this “Agreement”), dated as of January 11, 2019 (the “Effective Date”), by and between Tauriga Sciences Inc., located in New York, NY 10022 (the “Company”), and J. Safier Enterprises LLC, a sole proprietorship operated by Mr. Jamie Safier (“Mr. Safier”) with an address at 6 The Hemlocks / Roslyn, NY 11576 (the “Consultant”).
PER OS BIOSCIENCES CONTRACT MANUFACTURING AGREEMENT FOR CHEWING GUM Terms and ConditionsContract Manufacturing Agreement • January 29th, 2019 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • Maryland
January 15, 2019Securities Purchase Agreement • January 29th, 2019 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products
Tauriga Sciences, Inc., a Florida corporation (the “Company”), and Eagle Equities, LLC (the “Investor”) have entered into a Securities Purchase Agreement (“SPA”) dated January 15, 2019, providing for the issuance of an 8% Convertible Promissory Note with a principal amount of $62,000.00 (“Note”), referred to herein as the ‘Note’, as well as a side letter (the “Side Letter”, a copy of which has been provided to you as Transfer Agent) incorporated into and amending the terms of the SPA and Note.
